Search Orphan Drug Designations and Approvals
-
Generic Name: | duvelisib |
---|---|
Date Designated: | 10/02/2019 |
Orphan Designation: | Treatment of T-Cell Lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Secura Bio, Inc. 1995 Village Center Cir. Las Vegas, Nevada 89134-6360 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-